Angiex Reports AACR In Vivo Data Supporting AGX101 in Combination With Immune Checkpoint Inhibitors for Solid Tumors

Preclinical in vivo data suggest AGX101 may enhance checkpoint inhibitor activity through selective targeting of tumor ...

Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads ...

Potent preclinical efficacy with durable immune memory observed in combinations of either ACR-368 or ACR-2316 with anti-PD-L1 and strong synergy ...

Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or ...

The U.S. FDA has granted Fast Track designation for mRNA-4359 in combination with pembrolizumab for the treatment of ...
Healio

Checkpoint inhibition can be ‘like pouring lighter fluid onto the fire’ of inflammation

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Inflammatory arthritis as a result of immune checkpoint cancer therapy remains a pressing ...
The American Journal of Managed Care

Data Highlights Factors Impacting Immune Checkpoint Inhibitors in mCRC

MSI-H mCRC patients receiving ICIs had significantly improved OS compared to chemotherapy, with a 63% improvement in survival. MSS patients with high albumin levels or recent antibiotic use also ...
The Chosun Ilbo on MSN

Immune checkpoint inhibitors revolutionize cancer treatment

Mr. Kim, 62 years old, a man preparing for retirement, was an office worker diligently attending to his job just a year ago.
Healio

More than 40% of patients with rheumatoid arthritis report flares after checkpoint therapy

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Flares occurred in more than 40% of patients with ...

Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and A…

Potent preclinical efficacy with durable immune memory observed in combinations of either ACR-368 or ACR-2316 with anti-PD-L1 ...